Enhanced neuroprotective effect of fish oil in combination with quercetin against 3-nitropropionic acid induced oxidative stress in rat brain

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 40, Issue 1, 2013, Pages 83-92

  Denny Joseph, K M ^a   Muralidhara, ^a  

^a CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

Author keywords

3 Nitropropionic acid; Fish oil; Neurotoxicity; Oxidative stress; Quercetin; Rat

Indexed keywords

3 NITROPROPIONIC ACID; ACETYLCHOLINESTERASE; ADENOSINE TRIPHOSPHATASE; CARBONYL DERIVATIVE; CATALASE; DOPAMINE; FISH OIL; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; NITRIC OXIDE; QUERCETIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG POTENTIATION; ENZYME ACTIVITY; MALE; MOTOR DYSFUNCTION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; BRAIN; FISH OILS; GLUTATHIONE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NEUROPROTECTIVE AGENTS; NITRO COMPOUNDS; OXIDATIVE STRESS; PROPIONATES; QUERCETIN; RATS; RATS, WISTAR;

EID: 84867899061     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.08.018     Document Type: Article

References (71)

1. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-125.
2. Asanuma M., Hirata H., Cadet J.L. Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice. Neuroscience 1998, 85:907-917.
3. Bancroft L.K., Lupton J.R., Davidson L.A., Taddeo S.S., Murphy M.E., Carroll R.J., et al. Dietary fish oil reduces oxidative DNA damage in rat colonocytes. Free Radic Biol Med 2003, 35:149-159.
4. Berridge M.V., Tans A.S. Characterization of the cellular reduction of 3-(4,5-dimethyl thiazole-2-yl)-2,5-diphenyltetrazoliumbromide (MTT): subcellular localization, substrate dependence and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 1993, 303:474-482.
5. Bharath M.M.S., Hsu M., Kaur D., Andersen J.K. Glutathione, iron and Parkinson's disease. Biochem Pharmacol 2002, 64:1037-1048.
6. Bhutada P., Mundhada Y., Bansod K., Bhutada C., Tawari S., Dixit P., et al. Ameliorative effect of quercetin on memory dysfunction in streptozotocin-induced diabetic rats. Neurobiol Learn Mem 2010, 94:293-302.
7. Binienda Z.K., Beaudoin M.A., Gough B., Ali S.F., Virmani A. Assessment of 3-nitropropionic acid-evoked peripheral neuropathy in rats: neuroprotective effects of acetyl-l-carnitine and resveratrol. Neurosci Lett 2010, 480:117-121.
8. +-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Cell Mol Neurobiol 2009, 29:1169-1180.
9. Bousquet M., Gibrat M., Saint-Pierre M., Julien C., Calon F., Cichetti F. Modulation of brain derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in parkinsonian animal model. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1401-1408.
10. Camargo C., Eleonora M.F., da Silva M.E.F., da Silva R.A., Justo G.Z., Gomes-Marcondes M.C.C., et al. Inhibition of tumor growth by quercetin with increase of survival and prevention of cachexia in walker 256 tumor-bearing rats. Biochem Biophys Res Commun 2011, 406:638-642.
11. Camuesco D., Comalada M., Concha A., Nieto A., Sierra S., Xaus J., et al. Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis. Clin Nutr 2006, 25:466-476.
12. Cole G.M., Ma Q.L., Frautschy S.A. Omega-3 fatty acids and dementia. Prostaglandins Leukot Essent Fat Acids 2009, 81:213-221.
13. Dalpiaz A., Filosa K., de Caprariis P., Conte G., Bortolotti F., Biondi C., et al. Molecular mechanism involved in transport of a prodrug dopamine glycosyl conjugate. Int J Pharm 2007, 336:133-139.
14. Davis J.E., Murphy E.A., Carmichael M.D., Davis B. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol 2009, 296:R1071-R1077.
15. Delattre A.M., Kiss A., Szawka R.E., Anselmo-Franci J.A., Bagatini P.B., Xavier L.L., et al. Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease. Neurosci Res 2010, 66:256-264.
16. Denny Joseph K.M., Muralidhara Fish oil prophylaxis attenuates rotenone induced oxidative impairments and mitochondrial dysfunctions in rat brain. Food Chem Toxicol 2012, 50:1529-1537.
17. Denny Joseph K.M., Muralidhara Prophylactic neuromodulatory effect of fish oil supplements and synergistic action with quercetin against rotenone induced oxidative impairments in rat brain. XIX World Congress on Parkinson's Disease and Related Disorders, Shanghai, China, Dec 11-14, 2011 2012, (Parkinsonism Relat Disord 18S2 (2012b) s205). 10.1016/S1353-8020(11)70072-4.
18. Desaiah D., Philips T.D., Hayes A.W., Ho I.K. Effect of aflatoxins on ATPase activities in mouse and rat liver. J Environ Sci Health B 1979, 14:265-278.
19. Deshpande S.B., Hida H., Takei-Io N., Masuda T., Baba H., Nishino H. Involvement of nitric oxide in 3-nitropropionic acid-induced striatal toxicity in rats. Brain Res 2006, 1108:205-215.
20. Dhir A., Akula K.K., Kulkarni S.K., Tiagabine A. GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:835-843.
21. Dias A.S., Porawski M., Marroni N., Collado P.S., Gonza J. Quercetin decreases oxidative stress, NF-kB activation and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J Nutr 2005, 135:2299-2304.
22. Ellman G.E., Courtney K.D., Andersen V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961, 7:88-95.
23. Eradiri O.L., Starr M.S. Striatal dopamine depletion and behavioural sensitization induced by methamphetamine and 3-nitropropionic acid. Eur J Pharmacol 1999, 386:217-226.
24. Farooqui A.A., Ong W.Y., Horrocks L.A., Chen P., Farooqui T. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans. Brain Res Rev 2007, 56:443-471.
25. Farrar A.M., Callahan J.W., Abercrombie E.D. Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms. Exp Neurol 2011, 232:119-125.
26. Fernagut P.O., Diguet E., Stefanova N., Biran M., Wenning G.K., Canioni P., et al. Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult c57bl/6 mice: behavioural and histopathological characterisation. Neuroscience 2002, 114:1005-1017.
27. Fiske C.H., Subbarrow Y.J. The colorimetric determination of phosphorus. J Biol Chem 1925, 66:375-381.
28. Giunta B., Hou H., Zhu Y., Salemi J., Ruscin A., Shytle R.D., et al. Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 mice. Neurosci Lett 2010, 471:134-138.
29. Gnatek Y., Zimmerman G., Goll Y., Najami N., Soreq H., Friedman A. Acetylcholinesterase loosens the brain's cholinergic anti-inflammatory response and promotes epileptogenesis. Front Mol Neurosci 2012, 5:66.
30. Guthenberg C., Alin P., Mannervik B. Glutathione transferase from rat testis. Methods Enzymol 1985, 113:507-510.
31. Hashimoto M., Tanabe Y., Fujii Y., Kikuta T., Shibata H., Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid-β infused rats. J Nutr 2005, 135:549-555.
32. Herrera-Mundo N., Sitges M. Mechanisms underlying striatal vulnerability to 3-nitropropionic acid. J Neurochem 2010, 114:597-605.
33. Johnson E.J., McDonald K., Caldarella S.M., Chung H.Y., Troen A.M., Snodderly D.M. Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr Neurosci 2008, 11:75-83.
34. Kahraman A., Cakar H., Koken T. The protective effect of quercetin on long-term alcohol consumption-induced oxidative stress. Mol Biol Rep 2012, 39:2789-2794.
35. Kuhad A., Sethi R., Chopra K. Lycopene attenuates diabetes-associated cognitive decline in rats. Life Sci 2008, 83:128-134.
36. Kumar P., Kumar A. Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: possible role of nitric oxide. Neurosci Res 2009, 63:302-314.
37. Kumar P., Kumar A. Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:100-108.
38. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990, 186:464-478.
39. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurements using Folin-phenol reagent. J Biol Chem 1951, 193:265-275.
40. Luthman M., Holmgern A. Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochem J 1982, 21:6628-6633.
41. Ma Q.L., Yang F., Rosario E.R., Ubeda O.J., Beech W., Gant D.J., et al. Amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-jun n-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 2009, 29:9078-9089.
42. Mahdy H.M., Tadros M.G., Mohamed M.R., Karim A.M., Khalifa A.E. The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats. Neurochem Int 2011, 59:770-778.
43. Mattei R., Polotow T.G., Vardaris C.V., Guerra B.A., Leite J.R., Otton R., et al. Astaxanthin limits fish oil related oxidative insult in the anterior forebrain of Wistar rats: putative anxiolytic effects?. Pharmacol Biochem Behav 2011, 99:349-355.
44. Mazza M., Pomponi M., Janiri L., Bria P., Mazza S. Omega-3 fatty acids and antioxidants in neurological and psychiatric disease: an overview. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:12-26.
45. Mishra D., Flora S.J.S. Quercetin administration during chelation therapy protects arsenic-induced oxidative stress in mice. Biol Trace Elem Res 2008, 122:137-147.
46. Mokrasch L.C., Teschke E.J. Glutathione content of cultured cells and rodent brain regions: a specific fluorimetric assay. Anal Biochem 1984, 140:506-509.
47. Moreadith R.W., Fiskum J. Isolation of mitochondria from ascites tumor cells permeabilized with digitonin. Anal Biochem 1984, 137:60-67.
48. Mutairy A.A., Kadash A.A., Elfaki I., Arshaduddin M., Malik D., Moutaery K.A., et al. Trolox ameliorates 3-nitropropionic acid-induced neurotoxicity in rats. Neurotoxicol Teratol 2010, 32:226-233.
49. Naidu P.S., Singh A., Kulkarni S.K. Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia. Neuropharmacology 2003, 44:1100-1106.
50. Nam E., Lee S.M., Koh S.E., Joo W.S., Maeng S., Im H.I., et al. Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum. Brain Res 2005, 1046:90-96.
51. Nieto S., Garrido A., Sanhueza J., Loyola L.A., Morales G., Leighton F., et al. Flavonoids as stabilizers of fish oil: an alternative to synthetic antioxidants. J Amer Oil Chem Soc 1993, 70:773-778.
52. Ohakawa H., Ohnishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 9:351-358.
53. Orhan N., Erdogan I., Ergun F. Insights into cholinesterase inhibitory and antioxidant activities of five Juniperus species. Food Chem Toxicol 2011, 49:2305-2312.
54. Palacios-pelaez R., Lukiw W.J., Bazan N.G. Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease. Mol Neurobiol 2010, 41:367-374.
55. Park J.E., Lee S.T., Im W.S., Chu K., Kim M. Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease. Neurosci Lett 2008, 448:143-147.
56. Pennington R. Biochemistry of dystrophic muscle. Mitochondrial succinate-tetrazolium reductase and adenosine triphosphatase. Biochem J 1961, 80:649-654.
57. Perez-Mateos M., Bravo L., Goya L., Gomez-Guliien C., Montero P. Quercetin properties as a functional ingredient in omega-3 enriched fish gels fed to rats. J Sci Food Agric 2005, 85:1651-1659.
58. Pradat P.F., Kennel P., Naimi-Sadaoui S., Finiels F., Orcini C., Revah F., et al. Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies. Hum Gene Ther 2001, 12:2237-2249.
59. Sandhir R., Mehrotra A., Kamboj S.S. Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system. Neurochem Int 2010, 57:579-587.
60. Saulle E., Gubellini P., Picconi B., Centonze D., Propepi D., Pisani A., et al. Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease. Mol Cell Neurosci 2004, 25:9-20.
61. Schmatz R., Mazzanti C.M., Spanevello R., Stefanello N., Gutierres J., Corrêa M., et al. Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur J Pharmacol 2009, 610:42-48.
62. Shinomol G.K., Muralidhara Prophylactic neuroprotective property of Centella asiatica against 3-nitropropionic acid induced oxidative stress and mitochondrial dysfunctions in brain regions of prepubertal mice. Neurotoxicology 2008, 29:948-957.
63. Shinomol G.K., Srinivas Bharath M.M., Muralidhara Pretreatment with Bacopa monnieri extract offsets 3-nitropropionic acid induced mitochondrial oxidative stress and dysfunctions in striatum of prepubertal mouse brain. Canadian. J Physiol Pharmacol 2012, 90:595-606.
64. Sorolla M.A., Reverter-Branchat G., Tamarit J., Ferrer I., Ros J., Cabiscol E. Proteomic and oxidative stress analysis in human brain samples of Huntington disease. Free Radic Biol Med 2008, 45:667-678.
65. Sriraksa N., Wattanathorn J., Muchimapura S., Tiamkao S., Brown K., Chaisiwamongkol K. Cognitive-enhancing effect of quercetin in a rat model of Parkinson's disease induced by 6-hydroxydopamine. Evid Based Complement Alternat Med 2012, 10.1155/2012/823206.
66. Tota S., Awasthi H., Kumar P., Nath C., Hanif K. Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice. Behav Brain Res 2010, 209:73-79.
67. Tsuduki T., Honma T., Nakagawa K., Ikeda I., Miyazawa T. Long-term intake of fish oil increases oxidative stress and decreases lifespan in senescence-accelerated mice. Nutrition 2011, 27:334-337.
68. Tunez I., Tasset I., Cruz V.P.L., Santamaria A. 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future. Molecules 2010, 15:878-916.
69. Villarán R.F., Tomás-Camardiel M., de Pablos R.M., Santiago M., Herrera A.J., Navarro A., et al. Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production. Neurotoxicology 2008, 29:244-258.
70. Kostyuk V.A., Potapovich A.I. Superoxide driven oxidation of quercetin and a simple sensitive assay for determination of superoxide dismutase. Biochem Int 1989, 19:1117-1124.
71. Wolf S.P. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol 1994, 233:182-189.